Login
$ACAD
$18.47 -$0.20 (1.07%) After hours

Insider Transactions

What ACADIA PHARMACEUTICALS INC's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 1 24
Total trades 2 48

Shares traded

3 months 12 months
Acquired 6,815 224,482
Disposed 3,321 114,962
Net activity +3,494 +109,520

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Oct 30 Disclosed 10b5-1 sale · S −3,321 $20.88 −$69.3K 71,322
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Oct 15 Grant / award · A +6,815 — — 74,643
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Aug 06 Open-market sale · S −9,292 $29.34 −$273K 67,828
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Aug 06 Open-market sale · S −5,000 $29.00 −$145K 77,120
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Aug 06 Exercise / conversion · M +14,292 $17.84 +$255K 82,120
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Aug 05 Open-market sale · S −5,849 $29.00 −$170K 67,828
Schneyer Mark C. EVP, CHIEF FINANCIAL OFFICER Aug 05 Exercise / conversion · M +5,849 $17.84 +$104K 73,677
Thompson Elizabeth H.z. EVP, Head of Research & Dev Jul 30 Disclosed 10b5-1 sale · S −50 $26.17 −$1.31K 18,994
Thompson Elizabeth H.z. EVP, Head of Research & Dev Jul 30 Disclosed 10b5-1 sale · S −16,508 $26.13 −$431K 19,044
Thompson Elizabeth H.z. EVP, Head of Research & Dev Jul 29 Exercise / conversion · M +32,272 — — 35,552
Kihara James PRINCIPAL ACCOUNTING OFFICER Jun 26 Open-market sale · S −11,421 $26.08 −$298K 13,088
Daly James M Director May 29 Exercise / conversion · M +8,107 — — 12,148
Harrigan Edmund Director May 29 Exercise / conversion · M +8,107 — — 43,148
Baker Bros. Advisors Lp Director May 29 Grant / award · A +18,622 — — 39,384,587
Baker Bros. Advisors Lp Director May 29 Grant / award · A +18,622 — — 3,677,357
Brege Laura Director May 29 Exercise / conversion · M +8,107 — — 23,202
Poole Jonathan Director May 29 Exercise / conversion · M +2,010 — — 2,010
Garofalo Elizabeth A. Director May 29 Exercise / conversion · M +8,107 — — 33,489
Ndu Adora Director May 29 Exercise / conversion · M +8,107 — — 32,908
Kihara James PRINCIPAL ACCOUNTING OFFICER May 26 Open-market sale · S −5,401 $21.18 −$114K 24,509

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support